Matthew Vandermast

Chief Operating Officer at Oncovir - Washington, DC, US

Matthew Vandermast's Colleagues at Oncovir
Matthew Vandermast's Contact Details
HQ
202-342-1726
Location
Company
Oncovir
Matthew Vandermast's Company Details
Oncovir logo, Oncovir contact details

Oncovir

Washington, DC, US • 5 - 9 Employees
Major Drugs

Oncovir, Inc is a pharmaceutical corporation dedicated to the development of nucleic-acid-based clinical therapies for cancer, infectious, immune, and degenerative disorders.​We promote Hiltonol® (poly-ICLC) as an experimental viral mimic and broad activator of innate and adaptive immunity. While initially developed as an interferon inducer, Hiltonol® has much broader biological effects in humans, including specific antiviral, immune activating, vaccine adjuvant, and antitumor actions.

immunotherapy
Details about Oncovir
Frequently Asked Questions about Matthew Vandermast
Matthew Vandermast currently works for Oncovir.
Matthew Vandermast's role at Oncovir is Chief Operating Officer.
Matthew Vandermast's email address is ***@oncovir.com. To view Matthew Vandermast's full email address, please signup to ConnectPlex.
Matthew Vandermast works in the Pharmaceuticals industry.
Matthew Vandermast's colleagues at Oncovir are Eleanor Salazar, Peter MD, Peter Nigra, Andres M and others.
Matthew Vandermast's phone number is 202-342-1726
See more information about Matthew Vandermast